Major Program
Phase 0 I II Cancer Prevention Clinical Trials Program
Research Group
Breast and Gynecologic Cancer
Sponsor
National Cancer Institute (NCI)
Status
Active, not recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT02568566
Human papillomavirus (HPV) is a common sexually-transmitted virus which causes infections
that usually last only a few months, but sometimes can last a long time and cause cancers of
the cervix, vagina, vulva, anus or oropharynx over many years among adults. This phase IIA
trial studies how well does the nonavalent HPV vaccine (which can prevent nine different
types of HPV) work when given in an alternative dosing schedule to heathy young research
participants.
that usually last only a few months, but sometimes can last a long time and cause cancers of
the cervix, vagina, vulva, anus or oropharynx over many years among adults. This phase IIA
trial studies how well does the nonavalent HPV vaccine (which can prevent nine different
types of HPV) work when given in an alternative dosing schedule to heathy young research
participants.
Intervention
Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine
Condition
Human Papillomavirus-Related Carcinoma
Investigators
Yi Zeng